Results 1 to 10 of about 390,786 (264)

Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims Adjuvant chemotherapy is the standard of care for resected stage II–IIIA non-small cell lung cancer (NCSLC). The efficacy of adjuvant chemotherapy in stage IB (< 4 cm) NSCLC with high-risk factors is controversial.
Juwhan Choi, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Jae Jeong Shim, Sue In Choi, Dong Won Park, Chan Kwon Park, Eun Joo Kang, Hwan Seok Yong, Bong Kyung Shin, Hyun Koo Kim, Sung Yong Lee   +12 more
doaj   +1 more source

Differences in prognosis and underuse of adjuvant chemotherapy between elderly and non‐elderly patients in stage III colorectal cancer

Annals of Gastroenterological Surgery, 2023
Aim We aimed to clarify the use of adjuvant chemotherapy and the prognosis of elderly colorectal cancer patients compared with non‐elderly patients, and the usefulness of sarcopenia as an indicator for the introduction and completion of adjuvant ...
Takuya Shiraishi, Hiroomi Ogawa, Ikuma Shioi, Naoya Ozawa, Katsuya Osone, Takuhisa Okada, Makoto Sohda, Ken Shirabe, Hiroshi Saeki   +8 more
doaj   +1 more source

Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy. [PDF]

PLoS ONE, 2013
BACKGROUND: A phase III clinical trial has already shown the survival benefits of postoperative chemotherapy in gastric cancer. However, there are limited published data concerning the elderly.
Ying Jin, Miao-zhen Qiu, De-shen Wang, Dong-sheng Zhang, Chao Ren, Long Bai, Hui-yan Luo, Zhi-qiang Wang, Feng-hua Wang, Yu-hong Li, Rui-hua Xu   +10 more
doaj   +1 more source

Novel molecular classification of endometrial cancer - current and future clinical implications [PDF]

Vojnosanitetski Pregled, 2023
nema
Mandić Aljoša, Nađ Gabriel-Stefan, Stanulović Nevena, Maričić Slobodan, Gutić Bojana   +4 more
doaj   +1 more source

Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse [PDF]

Tuberculosis and Respiratory Diseases, 2023
A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the early and resectable stage. Despite the use of platinum-based adjuvant chemotherapy, there was only a marginal increase in overall survival and a 15 ...
Jeong Uk Lim
doaj   +1 more source

Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer

Scientific Reports, 2022
Concurrent chemoradiotherapy is the established treatment for locally advanced nasopharyngeal carcinoma (NPC). However, there is no evidence supporting routine adjuvant chemotherapy. We aimed to demonstrate the effect of adjuvant chemotherapy on survival
Mu-Hung Tsai, Shang-Yin Wu, Hsi-Huei Lu, Tsung Yu, Sen-Tien Tsai, Yuan-Hua Wu   +5 more
doaj   +1 more source

Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patients

Cancer Medicine, 2023
Background The survival of hemodialysis (HD) patients with cancer is poor, which may be caused by undertreatment due to renal dysfunction. Particularly, adjuvant chemotherapy after surgery may be considered optional because of its preventive nature. This
Taisuke Ishii, Tomone Watanabe, Takahiro Higashi   +2 more
doaj   +1 more source

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis

Frontiers in Oncology, 2022
BackgroundFor rectal cancer, it remains unclear how to incorporate tumor response to neoadjuvant chemoradiotherapy (nCRT) when deciding whether to give adjuvant chemotherapy.
Yu-Hsuan Kuo, Yu-Hsuan Kuo, Yun-Tzu Lin, Chung-Han Ho, Chung-Han Ho, Chia-Lin Chou, Chia-Lin Chou, Li-Chin Cheng, Chia-Jen Tsai, Wei-Ju Hong, Yi-Chen Chen, Ching-Chieh Yang, Ching-Chieh Yang   +12 more
doaj   +1 more source

Whether Patients With Stage Ⅱ/Ⅲ Colorectal Cancer Benefit From Adjuvant Chemotherapy: A Modeling Analysis of Literature Aggregate Data

Frontiers in Pharmacology, 2022
Objective: This study used model analysis to clarify the benefits and risks of postoperative adjuvant chemotherapy compared with surgery alone in patients with stage II/III colorectal cancer.Methods: Clinical trials involving patients with stage II/III ...
Sijie Zha, Ting Li, Qingshan Zheng, Lujin Li   +3 more
doaj   +1 more source

Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort

BMC Cancer, 2022
Background There is no clear consensus on the benefits of adjuvant chemotherapy for tumor-node-metastasis (TNM) stage T1 (T1N0M0) breast cancer (BC). Our study investigated the effects of adjuvant chemotherapy on T1N0M0 BC patients.
Kaiwen Shen, Longdi Yao, Jingyuan Zhu, Ximing Gu, Jie Wang, Wei Qian, Zhijian Zheng, Deyuan Fu, Song Wu   +8 more
doaj   +1 more source